These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 27028264)

  • 1. Observed Cognitive Performance and Deviation From Familial Cognitive Aptitude at Age 16 Years and Ages 18 to 20 Years and Risk for Schizophrenia and Bipolar Illness in a Swedish National Sample.
    Kendler KS; Ohlsson H; Mezuk B; Sundquist JO; Sundquist K
    JAMA Psychiatry; 2016 May; 73(5):465-71. PubMed ID: 27028264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Swedish National Prospective and Co-relative Study of School Achievement at Age 16, and Risk for Schizophrenia, Other Nonaffective Psychosis, and Bipolar Illness.
    Kendler KS; Ohlsson H; Mezuk B; Sundquist K; Sundquist J
    Schizophr Bull; 2016 Jan; 42(1):77-86. PubMed ID: 26231719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The joint impact of cognitive performance in adolescence and familial cognitive aptitude on risk for major psychiatric disorders: a delineation of four potential pathways to illness.
    Kendler KS; Ohlsson H; Keefe RSE; Sundquist K; Sundquist J
    Mol Psychiatry; 2018 Apr; 23(4):1076-1083. PubMed ID: 28416810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shared neurocognitive dysfunctions in young offspring at extreme risk for schizophrenia or bipolar disorder in eastern quebec multigenerational families.
    Maziade M; Rouleau N; Gingras N; Boutin P; Paradis ME; Jomphe V; Boutin J; Létourneau K; Gilbert E; Lefebvre AA; Doré MC; Marino C; Battaglia M; Mérette C; Roy MA
    Schizophr Bull; 2009 Sep; 35(5):919-30. PubMed ID: 18550590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Neurocognitive Functions in 7-Year-Old Children at Familial High Risk for Schizophrenia or Bipolar Disorder: The Danish High Risk and Resilience Study VIA 7.
    Hemager N; Plessen KJ; Thorup A; Christiani C; Ellersgaard D; Spang KS; Burton BK; Gregersen M; Søndergaard A; Greve AN; Gantriis DL; Poulsen G; Seidman LJ; Mors O; Nordentoft M; Jepsen JRM
    JAMA Psychiatry; 2018 Aug; 75(8):844-852. PubMed ID: 29926086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High educational performance is a distinctive feature of bipolar disorder: a study on cognition in bipolar disorder, schizophrenia patients, relatives and controls.
    Vreeker A; Boks MP; Abramovic L; Verkooijen S; van Bergen AH; Hillegers MH; Spijker AT; Hoencamp E; Regeer EJ; Riemersma-Van der Lek RF; Stevens AW; Schulte PF; Vonk R; Hoekstra R; van Beveren NJ; Kupka RW; Brouwer RM; Bearden CE; MacCabe JH; Ophoff RA;
    Psychol Med; 2016 Mar; 46(4):807-18. PubMed ID: 26621616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. School Achievement, IQ, and Risk of Alcohol Use Disorder: A Prospective, Co-Relative Analysis in a Swedish National Cohort.
    Kendler KS; Ohlsson H; Sundquist J; Sundquist K
    J Stud Alcohol Drugs; 2017 Mar; 78(2):186-194. PubMed ID: 28317498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive deficits in early-onset schizophrenia spectrum patients and their non-psychotic siblings: a comparison with ADHD.
    Groom MJ; Jackson GM; Calton TG; Andrews HK; Bates AT; Liddle PF; Hollis C
    Schizophr Res; 2008 Feb; 99(1-3):85-95. PubMed ID: 18083349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Family Genetic Risk Scores and the Genetic Architecture of Major Affective and Psychotic Disorders in a Swedish National Sample.
    Kendler KS; Ohlsson H; Sundquist J; Sundquist K
    JAMA Psychiatry; 2021 Jul; 78(7):735-743. PubMed ID: 33881469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurocognitive function in clinically stable patients with schizophrenia or bipolar disorder and normal controls].
    Konstantakopoulos G; Ioannidi N; Patrikelis P; Soumani A; Oulis P; Sakkas D; Papadimitriou GN; Ploumpidis D
    Psychiatriki; 2011; 22(3):195-206. PubMed ID: 21971195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IQ and schizophrenia in a Swedish national sample: their causal relationship and the interaction of IQ with genetic risk.
    Kendler KS; Ohlsson H; Sundquist J; Sundquist K
    Am J Psychiatry; 2015 Mar; 172(3):259-65. PubMed ID: 25727538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive function in childhood and early adulthood and hospital admission for schizophrenia and bipolar disorders in Danish men born in 1953.
    Osler M; Lawlor DA; Nordentoft M
    Schizophr Res; 2007 May; 92(1-3):132-41. PubMed ID: 17344025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.
    Jabben N; Arts B; van Os J; Krabbendam L
    J Clin Psychiatry; 2010 Jun; 71(6):764-74. PubMed ID: 20122370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficits in visual sustained attention differentiate genetic liability and disease expression for schizophrenia from Bipolar Disorder.
    Kumar CT; Christodoulou T; Vyas NS; Kyriakopoulos M; Corrigall R; Reichenberg A; Frangou S
    Schizophr Res; 2010 Dec; 124(1-3):152-60. PubMed ID: 20674278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuity and discontinuity of affective disorders and schizophrenia. Results of a controlled family study.
    Maier W; Lichtermann D; Minges J; Hallmayer J; Heun R; Benkert O; Levinson DF
    Arch Gen Psychiatry; 1993 Nov; 50(11):871-83. PubMed ID: 8215813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Psychiatric and Neurodevelopmental Disorders Among Siblings of Probands With Autism Spectrum Disorders.
    Jokiranta-Olkoniemi E; Cheslack-Postava K; Sucksdorff D; Suominen A; Gyllenberg D; Chudal R; Leivonen S; Gissler M; Brown AS; Sourander A
    JAMA Psychiatry; 2016 Jun; 73(6):622-9. PubMed ID: 27145529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Executive dysfunctions as potential markers of familial vulnerability to bipolar disorder and schizophrenia.
    Zalla T; Joyce C; Szöke A; Schürhoff F; Pillon B; Komano O; Perez-Diaz F; Bellivier F; Alter C; Dubois B; Rouillon F; Houde O; Leboyer M
    Psychiatry Res; 2004 Jan; 121(3):207-17. PubMed ID: 14675740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder.
    Green MF
    J Clin Psychiatry; 2006 Oct; 67(10):e12. PubMed ID: 17107235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Schizophrenia and/or bipolar disorder: the neurocognitive endophenotypes].
    Kaladjian A; Azorin JM; Pomietto P; Corréard N; Belzeaux R; Adida M
    Encephale; 2012 Dec; 38 Suppl 3():S81-4. PubMed ID: 23279993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive ability in Swedish conscripts and future risk of venous thromboembolism: A co-relative prospective national study.
    Zöller B; Ohlsson H; Sundquist J; Sundquist K
    Eur J Intern Med; 2016 May; 30():68-71. PubMed ID: 26827099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.